Name: Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge (en Inglés)
Price: 857.90 MXN
Availability: InStock
Author: Onetti, Alberto ; Zucchella, Antonella
ISBN: 9781138616905

Envío gratis

portada Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge (en Inglés)

Formato

Libro Físico

Autor

Antonella Zucchella

Alberto Onetti

Editorial

Routledge

Año

2018

Idioma

Inglés

N° páginas

196

Encuadernación

Tapa Blanda

ISBN13

9781138616905

N° edición

Categorías

Gestión de proyectos de investigación y desarrollo
La industria manufacturera
Biotecnología

Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge (en Inglés)

Antonella Zucchella (Autor) · Alberto Onetti (Autor) · Routledge · Tapa Blanda

Libro Nuevo

$ 857.90

$ 1,559.83

Ahorras: $ 701.92

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 20 de Junio y el Viernes 05 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Business Modeling for Life Science and Biotech Companies: Creating Value and Competitive Advantage with the Milestone Bridge (en Inglés)"

Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used 'business model' term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization's activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.